Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.

Detalles Bibliográficos
Autor principal: Younes, Cherradi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256602/
https://www.ncbi.nlm.nih.gov/pubmed/32527653
http://dx.doi.org/10.1016/j.dld.2020.05.039
_version_ 1783539947260608512
author Younes, Cherradi
author_facet Younes, Cherradi
author_sort Younes, Cherradi
collection PubMed
description
format Online
Article
Text
id pubmed-7256602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72566022020-05-29 Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak. Younes, Cherradi Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020-11 2020-05-29 /pmc/articles/PMC7256602/ /pubmed/32527653 http://dx.doi.org/10.1016/j.dld.2020.05.039 Text en © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Younes, Cherradi
Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
title Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
title_full Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
title_fullStr Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
title_full_unstemmed Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
title_short Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
title_sort fecal calprotectin and rt-pcr from both nasopharyngeal swab and stool samples prior to treatment decision in ibd patients during covid-19 outbreak.
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256602/
https://www.ncbi.nlm.nih.gov/pubmed/32527653
http://dx.doi.org/10.1016/j.dld.2020.05.039
work_keys_str_mv AT younescherradi fecalcalprotectinandrtpcrfrombothnasopharyngealswabandstoolsamplespriortotreatmentdecisioninibdpatientsduringcovid19outbreak

Ejemplares similares